A randomized, open-label, multi-center, comparative study of the efficacy and safety of piperacillin/tazobactam to cefepime for the empiric treatment of neutropenic fever in patients with a hematologic malignancy or lymphoma
Phase of Trial: Phase III
Latest Information Update: 08 Oct 2007
At a glance
- Drugs Cefepime; Piperacillin/tazobactam
- Indications Bacterial infections; Immunocompromised infections
- Focus Therapeutic Use
- 08 Oct 2007 Status changed from in progress to completed.
- 30 Sep 2005 New trial record.